{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:59Z","timestamp":1791229499728,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.anai.2020.08.396","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T01:07:49Z","timestamp":1599354469000},"page":"162-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Descriptive analysis of a simplified approach to low-risk drug hypersensitivity reactions"],"prefix":"10.1016","volume":"126","author":[{"given":"Diana Luc\u00eda","family":"Silva Espinosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly Vanessa","family":"Rojas Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Fernando","family":"Ram\u00edrez Zuluaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Olaya Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Daniel","family":"Serrano Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.anai.2020.08.396_bib1","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2174\/138161208786369731","article-title":"Provocation tests in diagnosing drug hypersensitivity","volume":"14","author":"Bousquet","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.anai.2020.08.396_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.anai.2014.06.019","article-title":"Multinational experience with hypersensitivity drug reactions in Latin America","volume":"113","author":"Jares","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2020.08.396_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2500\/aap.2011.32.3450","article-title":"Outcomes and safety of drug provocation tests","volume":"32","author":"Aun","year":"2011","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"10.1016\/j.anai.2020.08.396_bib4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaip.2014.08.001","article-title":"Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review","volume":"2","author":"Iammatteo","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2020.08.396_bib5","doi-asserted-by":"crossref","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.anai.2020.08.396_bib6","first-page":"259","article-title":"Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma, and Immunology, American College of Allergy, Asthma, and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.08.396_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1398-9995.2006.01268.x","article-title":"Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy","volume":"62","author":"Fontaine","year":"2007","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.anai.2020.08.396_bib8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2020.08.396_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2222.2007.02656.x","article-title":"Continued need of appropriate betalactam-derived skin test reagents for the management of allergy to betalactams","volume":"37","author":"Blanca","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"1-2","key":"10.1016\/j.anai.2020.08.396_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000048905","article-title":"Adverse drug reactions: mechanisms and assessment","volume":"34","author":"Ring","year":"2002","journal-title":"Eur Surg Res"},{"issue":"1","key":"10.1016\/j.anai.2020.08.396_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2222.2008.03155.x","article-title":"BSACI guidelines for the management of drug allergy","volume":"39","author":"Mirakian","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.anai.2020.08.396_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs \u2013 an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2020.08.396_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2018.09.022","article-title":"Controversies in drug allergy: in\u00a0vitro testing","volume":"143","author":"Mayorga","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2020.08.396_bib14","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","article-title":"Self-reported drug allergy in a general adult Portuguese population","volume":"34","author":"Gomes","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2020.08.396_bib15","series-title":"Tratado de Alergolog\u00eda","first-page":"1657","article-title":"Concentraciones de principios activos y excipientes empleados para la realizaci\u00f3n de pruebas cut\u00e1neas y epicut\u00e1neas","author":"Lobera-Labairu","year":"2016"},{"issue":"4","key":"10.1016\/j.anai.2020.08.396_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.47102\/annals-acadmedsg.V42N4p184","article-title":"Clinical characteristics and outcomes of patients undergoing drug provocation tests (DPTs)","volume":"42","author":"Thalayasingam","year":"2013","journal-title":"Ann Acad Med Singap"},{"issue":"3","key":"10.1016\/j.anai.2020.08.396_bib17","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1067\/mai.2002.122214","article-title":"Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions","volume":"109","author":"Adkinson","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2020.08.396_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.iac.2004.03.010","article-title":"Classification and epidemiology of hypersensitivity drug reactions","volume":"24","author":"Demoly","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.anai.2020.08.396_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000323898","article-title":"Patients\u2019 satisfaction with diagnostic drug provocation tests and perception of its usefulness","volume":"156","author":"Gomes","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"10.1016\/j.anai.2020.08.396_bib20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2020.08.396_bib21","first-page":"363","article-title":"Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients","volume":"22","author":"Do\u00f1a","year":"2012","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2020.08.396_bib22","first-page":"130","article-title":"Evaluation of drug provocation tests in Korean children: a single center experience","volume":"34","author":"Choi","year":"2016","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2020.08.396_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World Allergy Organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.anai.2020.08.396_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinids\/13.4.697","article-title":"Adverse virus-drug interactions","volume":"13","author":"Haverkos","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"1-2","key":"10.1016\/j.anai.2020.08.396_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8010-9","article-title":"A\u00a0complex interaction between drug allergy and viral infection","volume":"33","author":"Shiohara","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.08.396_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anai.2016.10.003","article-title":"Skin testing and drug challenge outcomes in antibiotic-allergic patients with immediate-type hypersensitivity","volume":"118","author":"Mawhirt","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2020.08.396_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.anai.2018.03.010","article-title":"Systematic review of professional liability when prescribing \u03b2-lactams for patients with a known penicillin allergy","volume":"121","author":"Jeffres","year":"2018","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620309984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620309984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:26:32Z","timestamp":1761053192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120620309984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1081120620309984"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2020.08.396","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Descriptive analysis of a simplified approach to low-risk drug hypersensitivity reactions","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2020.08.396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}